期刊文献+

我国中药产品出口贸易形势及政策法规影响的分析 被引量:12

Analysis of the Situation of Export Trade of Traditional Chinese Medicine Productsin China and the Influence of Policies and Regulations
下载PDF
导出
摘要 中药是我国民族的瑰宝,近年来,我国对中药国际化重视程度日益提升,但是中药在出口贸易方面也面临着不少问题。通过对2009-2016年中药产品出口贸易情况的全面回顾,从贸易增长幅度、产品出口结构、市场分布、重点市场、重点品种等角度分析我国中药出口贸易的现状和问题,并以欧盟和"一带一路"为例分析政策法规的影响,探讨我国中药产品在出口时面临的问题,并提出相应对策。 Traditional Chinese medicine is a national treasure of our country. In recent years,China has paid more and more attention to the internationalization of traditional Chinese medicine. However,there are also many problems in the export trade of traditional Chinese medicine. By making a comprehensive review of the export trade of Chinese medicine products from 2009 to 2016,and the current situation and problems of traditional Chinese medicine in the export trade are analyzed from the magnitude of trade growth,product export structure,market distribution,key markets and key varieties,and take the EU and " One Belt and One Road" as examples to analyze the influence of policies and regulations,this paper explored the problems when exporting Chinese traditional medicine products and to put forward corresponding countermeasures.
作者 汪建芬 邢迪 张中朋 乔艺涵 林瑞超 WANG Jian-fen;XING Di;ZHANG Zhong-peng;QIAO Yi-han;LIN Rui-chao(Traditional Chinese Medicine Quality Evaluation of the Key Laboratory of Beijing,Belting University of Chinese Medicine,Beijing 100102,China;Jining City in Shandong Province Jinxiang Hospital of traditional Chinese medicine,Jining 272200,China;China Chamber of Commerce for Import & Export of Medicincs & Health Products,Beijing 100010,China)
出处 《中国现代中药》 CAS 2018年第8期915-919,927,共6页 Modern Chinese Medicine
关键词 中药 出口贸易 欧盟 “一带一路” traditional Chinese Medicine export trade EU One Belt and Road
  • 相关文献

参考文献3

二级参考文献17

  • 1刘平羽,陈永法.欧盟药物审评程序及要求[J].上海医药,2004,25(8):350-352. 被引量:1
  • 2郑永锋.欧洲草药药品管理相关指令评析[J].中国中医药信息杂志,2006,13(3):1-5. 被引量:2
  • 3苏刚强;李伯刚.欧盟草药药品注册指南[M]北京:人民卫生出版社,2005.
  • 4Cooke E.欧盟对药品管理的立法以及药监法规的法律背景.
  • 5Council of the European Economic Community. Council Directive of 26 January 1965 on the approximation of provisions laid down by law,regulation or administrative action relating to medicinal products(65/65/EEC)[OL].http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=DD:I:1965-1966:31965L0065:EN:PDF,2013.
  • 6Council of the European Economic Community. Council Directive of 20 May 1975 on the approximation of the laws of Member States relating to analytical,pharmaco-toxicological and clinical standards and protocols in respect of the testing of proprietary medicinal products(75/318/EEC)[OL].http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:1975:147:0001:0012:EN:PDF,2013.
  • 7European Medicines Agency. Second Council Directive 75/319/ EEC of 20 May 1975 on the approximation of provisions laid down by Law,Regulation or Administrative Action relating to proprietary medicinal products[OL].http://eur-lex.europa.eu/ LexUriServ/LexUriServ.do?uri=CELEX:31975L0319:EN:HTML,2013.
  • 8European Medicines Agency. Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use[OL].http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:32001L0083:EN:HTML,2013.
  • 9European Medicines Agency. Commission Directive 2003/63/EC of 25 June 2003 amending Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use (Text with EEA relevance)[OL].http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2003:159:0046:0094:EN:PDF,2013.
  • 10European Medicines Agency. Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use (Text with EEA relevance)[OL].http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2004:136:0034:0057:EN:PDF,2013.

共引文献6

同被引文献154

引证文献12

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部